Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +48.08%
#3 Akedo Akedo +40.50%
#4 Velvet Velvet +35.26%
#5 Black Phoenix Black Phoenix +34.23%
#6 Cross Cross +19.18%
#7 DoubleZero DoubleZero +18.36%
#8 Tutorial Tutorial +15.48%
#9 Cap Cap +14.84%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.23%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Classificação em ações #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Preço da ação
$0.11725176
Última sincronização: 2025-07-14
Valor de mercado
$481.50K
Variação (1 dia)
-0.20%
Variação (1 ano)
0.00%
País
FR
Negociar PHAXIAM Therapeutics S.A. (PHXM)

Categoria

Healthcare
EPS de PHAXIAM Therapeutics S.A. (PHXM)
EPS em June 2024 TTM: $-4.23
De acordo com os últimos relatórios financeiros e o preço das ações da PHAXIAM Therapeutics S.A., o EPS atual da empresa (TTM) é $-4.23. No final de 2022, a empresa teve um EPS de $-0.07, uma diminuição em relação a ao EPS de 2021, que foi de $-23.87.
Histórico de EPS da PHAXIAM Therapeutics S.A. de 2016 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-4.23 -23.50%
2023 $-5.53 7,492.45%
2022 $-0.07 -99.69%
2021 $-23.87 -46.82%
2020 $-44.88 23.87%
2019 $-36.23 60.03%
2018 $-22.64 -30.76%
2017 $-32.70 21.96%
2016 $-26.81 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -509.44%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -755.76%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -423.86%
BE